China

Home / China / Latest

Sinopharm applies for vaccine market approval

chinadaily.com.cn | Updated: 2020-11-25 14:29

Share

Share - WeChat

A staff member displays a sample of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group Co Ltd (Sinopharm) in Beijing, capital of China, April 10, 2020. [Photo/Xinhua]

Leading COVID-19 vaccine developer Sinopharm has submitted a market approval application to the top market regulator, according to media reports.

Photo

Water mahjong games cool visitors in Chongqing

Hundreds attend 5th TCM Culture Festival in Tianjin

Jishou's vegetable bus boosts farmer incomes

Renovation of Tianma tourism block completed in China's Xinjiang

In pics: A revisit to memorial hall of former headquarters of New Fourth Army in E China's Anhui

Duku Highway sees tourism boom in summer

Latest

State Council News

A look at China's economy in H1 of 2025

Exclusive

Best destinations to escape summer heat

High-speed rail: Driving China's modernization

St. Petersburg official: SCO nations achieve fruitful outcomes through cultural exchanges

Newsmaker

For a ranger, no mountain is too high to climb

Lychee grower enjoys fruits of global recognition

Ten photos you don't wanna miss

Ten photos from across China: July 11 – 17

Special Coverage

The Real Xinjiang through a Thousand Voices

2025 NPC & CPPCC National Committee annual sessions

BACK TO THE TOP

English

中文

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.

Registration Number: 130349

About China Daily

Advertise on Site

Expat Employment

FOLLOW US